Corcept Therapeutics
CORT
#1686
Rank
$12.56 B
Marketcap
$116.23
Share price
1.93%
Change (1 day)
35.97%
Change (1 year)

Corcept Therapeutics (CORT) - P/B ratio

P/B ratio as of October 2026 : 17.8

According to Corcept Therapeutics 's latest financial reports the company has a price-to-book ratio of 15.1216.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Corcept Therapeutics - P/B ratio (from 2004 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-316.21-23.19%
2024-12-318.0922.43%
2023-12-316.6151.66%
2022-12-314.36-28.38%
2021-12-316.084.75%
2020-12-315.8155.51%
2019-12-313.73-32.97%
2018-12-315.57-48.39%
2017-12-3110.8-44.6%
2016-12-3119.5-34%
2015-12-3129.5-132.88%
2014-12-31-89.8-688.73%
2013-12-3115.3560.05%
2012-12-312.31-72.08%
2011-12-318.28-37.09%
2010-12-3113.267.34%
2009-12-317.86161.86%
2008-12-313.00-63.8%
2007-12-318.2966.66%
2006-12-314.9860.13%
2005-12-313.110.9%
2004-12-313.08
2003-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.27-59.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6.36-64.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.84-89.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
30.0 68.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
8.45-52.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
5.57-68.70%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-17.8-200.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-2.66-114.95%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
1.77-90.07%๐Ÿ‡บ๐Ÿ‡ธ USA